CNS Drugs Journal Issues Research Articles in November 2023 Edition
November 24, 2023
November 24, 2023
CHAM, Switzerland, Nov. 24 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its November 2023 edition (Vol. 37, Issue 11):
* Efficacy and Safety of MAO-B Inhibitors Safinamide and Zonisamide in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Contr . . .
* Efficacy and Safety of MAO-B Inhibitors Safinamide and Zonisamide in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Contr . . .